{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:27Z","timestamp":1792784007213,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Shimberg Health Sciences Library"},{"DOI":"10.13039\/100008900","name":"University of South Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaad.2020.02.066","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T20:19:50Z","timestamp":1583525990000},"page":"1553-1567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults"],"prefix":"10.1016","volume":"82","author":[{"given":"Lucia","family":"Seminario-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kroshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Malachowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Markova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Beachkofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N.","family":"Ergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mauskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela R.","family":"Cardones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chodosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cotliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"DeNiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo R.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Eljure-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Femia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Guda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pasieka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahand","family":"Rahnama-Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajirah N.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Saunderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Strowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolyn A.","family":"Wanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Worswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.alit.2015.01.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013","volume":"64","author":"Abe","year":"2015","journal-title":"Allergol Int"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.066_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.066_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany","volume":"127","author":"Schopf","year":"1991","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pds.3937","article-title":"Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry","volume":"25","author":"Diphoorn","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"issue":"19","key":"10.1016\/j.jaad.2020.02.066_bib7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Investig Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.02.066_bib9","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jid.2018.04.027","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States","volume":"138","author":"Micheletti","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.burns.2015.12.001","article-title":"Burn unit care of Stevens Johnson syndrome\/toxic epidermal necrolysis: a survey","volume":"42","author":"Le","year":"2016","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","article-title":"Toxic epidermal necrolysis clinical guidelines","volume":"29","author":"Endorf","year":"2008","journal-title":"J Burn Care Res"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4103\/0378-6323.191134","article-title":"Guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis: an Indian perspective","volume":"82","author":"Gupta","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13023-018-0793-7","article-title":"Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)","volume":"13","author":"Ingen-Housz-Oro","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis-a comprehensive review and guide to therapy. II. Ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2020.02.066_bib17","series-title":"The RAND\/UCLA Appropriateness Method User\u2019s Manual","author":"Fitch","year":"2001"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.066_bib18","first-page":"589","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica","volume":"62","author":"East-Innis","year":"2013","journal-title":"West Indian Med J"},{"key":"10.1016\/j.jaad.2020.02.066_bib19","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/j.ejim.2013.08.718","article-title":"Stevens-Johnson Syndrome in a ward of internal medicine","volume":"24","author":"Cunha LA","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.066_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1365-4362.1997.00100.x","article-title":"Toxic epidermal necrolysis\u2014a retrospective study","volume":"36","author":"Criton","year":"1997","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.02.066_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.02.066_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/milmed\/167.8.701","article-title":"A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center","volume":"167","author":"Ellis","year":"2002","journal-title":"Mil Med"},{"issue":"16","key":"10.1016\/j.jaad.2020.02.066_bib23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.1987.03390160057026","article-title":"Toxic epidermal necrolysis. A step forward in treatment","volume":"257","author":"Heimbach","year":"1987","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.066_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.burns.2016.07.026","article-title":"Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: a 15-year experience","volume":"43","author":"McCullough","year":"2017","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809020-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","article-title":"Long-term follow-up of patients treated for toxic epidermal necrolysis","volume":"27","author":"Oplatek","year":"2006","journal-title":"J Burn Care Res"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaad.2013.12.048","article-title":"Toxic epidermal necrolysis and\u00a0early transfer to a regional burn unit: is it time to reevaluate what we teach?","volume":"71","author":"Kaffenberger","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jaad.2018.03.032","article-title":"Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"79","author":"Castillo","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.02.066_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bjps.2014.04.003","article-title":"Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm","volume":"67","author":"Abela","year":"2014","journal-title":"J Plast Reconstr Aesth Surg"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.burns.2008.12.011","article-title":"Accurate debridement of toxic epidermal necrolysis using Versajet\u00ae","volume":"36","author":"Dillon","year":"2010","journal-title":"Burns"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.burns.2017.09.015","article-title":"Improving mortality outcomes of Stevens Johnson syndrome\/toxic epidermal necrolysis: a regional burns centre experience","volume":"44","author":"Nizamoglu","year":"2018","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib33","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.jaad.2018.05.1258","article-title":"Wound management strategies in Stevens-Johnson syndrome\/toxic epidermal necrolysis: an unmet need","volume":"79","author":"Lee","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/PRS.0b013e3181773d5d","article-title":"Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach","volume":"122","author":"Dorafshar","year":"2008","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.dsi.2013.09.008","article-title":"French referral center management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"31","author":"Valeyrie-Allanore","year":"2013","journal-title":"Dermatol Sin"},{"issue":"15","key":"10.1016\/j.jaad.2020.02.066_bib36","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1517\/14656566.2010.515587","article-title":"Topical treatment options for drug-induced toxic epidermal necrolysis (TEN)","volume":"11","author":"Paquet","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.ASW.0000445919.06416.32","article-title":"Clinical evaluation comparing the efficacy of Aquacel Ag with Vaseline gauze versus 1% silver sulfadiazine cream in toxic epidermal necrolysis","volume":"27","author":"Huang","year":"2014","journal-title":"Adv Skin Wound Care"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.burns.2006.12.008","article-title":"AQUACEL Ag in the treatment of toxic epidermal necrolysis (TEN)","volume":"34","author":"Huang","year":"2008","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.burns.2009.02.018","article-title":"Aquacel Ag with Vaseline gauze in the management of toxic epidermal necrolysis (TEN)","volume":"36","author":"Huang","year":"2010","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ajd.12254","article-title":"Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN\/Stevens-Johnson syndrome overlap","volume":"56","author":"Smith","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.burns.2006.11.010","article-title":"A clinical experience of treating exfoliative wounds using nanocrystalline silver-containing dressings (Acticoat)","volume":"33","author":"Yang","year":"2007","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/bjophthalmol-2014-305506","article-title":"Severity of acute ocular involvement is independently associated with time to resolution of ocular disease in toxic epidermal necrolysis patients","volume":"99","author":"Heng","year":"2015","journal-title":"Br J Opthalmol"},{"issue":"9","key":"10.1016\/j.jaad.2020.02.066_bib43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archdermatol.2009.540","article-title":"Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"145","author":"Gueudry","year":"2009","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.02.066_bib45","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","article-title":"Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications","volume":"116","author":"Sotozono","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajo.2010.04.026","article-title":"Ophthalmic manifestations of Stevens-Johnson Syndrome and toxic epidermal necrolysis and relation to SCORTEN","volume":"150","author":"Morales","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ophtha.2010.06.035","article-title":"Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis","volume":"118","author":"Lopez-Garcia","year":"2011","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series","volume":"62","author":"Yip","year":"2007","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICU.0b013e3283622718","article-title":"Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"24","author":"Ciralsky","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.survophthal.2016.01.004","article-title":"Stevens-Johnson syndrome: the role of an ophthalmologist","volume":"61","author":"Jain","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ophtha.2011.01.046","article-title":"Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases","volume":"118","author":"Gregory","year":"2011","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1016\/j.jaad.2020.02.066_bib54","first-page":"173","article-title":"Amniotic membrane transplantation (AMT) without the use of sutures\/fibrin glue","volume":"7","author":"Agrawal","year":"2015","journal-title":"Nepal J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.066_bib55","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/ICO.0b013e31823d02a8","article-title":"Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study","volume":"31","author":"Hsu","year":"2012","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0161-6420(01)00900-9","article-title":"Amniotic membrane in the surgical management of acute toxic epidermal necrolysis","volume":"109","author":"John","year":"2002","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2015.07.002","article-title":"A novel technique for amniotic membrane transplantation in patients with acute Stevens-Johnson syndrome","volume":"14","author":"Ma","year":"2016","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajo.2009.08.040","article-title":"Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids","volume":"149","author":"Shammas","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BCR.0b013e31822b0f29","article-title":"Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib61","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ICU.0000000000000312","article-title":"Ocular manifestations of Stevens-Johnson syndrome and their management","volume":"27","author":"Saeed","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/0973-029X.125214","article-title":"Oral lesions associated with nevirapine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of 10 cases","volume":"17","author":"Reddy","year":"2013","journal-title":"J Oral Maxillofac Pathol"},{"issue":"8429","key":"10.1016\/j.jaad.2020.02.066_bib63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(85)92146-4","article-title":"Sjogren-like syndrome after drug-induced toxic epidermal necrolysis","volume":"1","author":"Roujeau","year":"1985","journal-title":"Lancet"},{"issue":"784","key":"10.1016\/j.jaad.2020.02.066_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/pgmj.67.784.195","article-title":"Sjogren-like pluriglandular exocrine insufficiency after drug-induced toxic epidermal necrolysis","volume":"67","author":"Saban","year":"1991","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib65","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.tripleo.2007.12.023","article-title":"Toxic epidermal necrolysis with a rare long-term oral complication requiring surgical intervention","volume":"105","author":"Sedghizadeh","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cden.2013.12.007","article-title":"Oral graft-versus-host disease","volume":"58","author":"Kuten-Shorrer","year":"2014","journal-title":"Dent Clin North Am"},{"issue":"10","key":"10.1016\/j.jaad.2020.02.066_bib67","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbmt.2019.09.029","article-title":"Long-term utilization patterns of topical therapy and clinical outcomes of oral chronic graft-versus-host disease","volume":"26","author":"Shazib","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.annder.2016.09.680","article-title":"Oral care recommendations for patients with oral autoimmune bullous\u00a0diseases [in French]","volume":"144","author":"Sobocinski","year":"2017","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14656566.2017.1282464","article-title":"Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide","volume":"18","author":"Zadik","year":"2017","journal-title":"Expert Opin Parmacother"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.066_bib71","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.1994.12.12.2630","article-title":"Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis","volume":"12","author":"Foote","year":"1994","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0030-4220(91)90300-2","article-title":"Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases","volume":"71","author":"Lozada-Nur","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib73","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1470-2045(17)30109-2","article-title":"Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial","volume":"18","author":"Rugo","year":"2017","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2020.02.066_bib74","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1111\/jdv.14284","article-title":"Oral lichenoid reactions associated with anti-PD-1\/PD-L1 therapies: clinicopathological findings","volume":"31","author":"Sibaud","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2020.02.066_bib75","first-page":"3179","article-title":"Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients","volume":"21","author":"Nicolatou-Galitis","year":"2013","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.jaad.2020.02.066_bib76","first-page":"3949","article-title":"Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"27","author":"Hong","year":"2019","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib77","first-page":"153","article-title":"Vulvovaginal sequelae in toxic epidermal necrolysis","volume":"42","author":"Meneux","year":"1997","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0029-7844(97)00596-6","article-title":"Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 cases","volume":"91","author":"Meneux","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib79","doi-asserted-by":"crossref","first-page":"490.e1","DOI":"10.1016\/j.jpurol.2017.01.018","article-title":"Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"13","author":"Van Batavia","year":"2017","journal-title":"J Pediatr Urol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib80","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/BCR.0b013e31829a4374","article-title":"The first reported case of ureteral perforation in a patient with severe toxic epidermal necrolysis syndrome","volume":"35","author":"Baccaro","year":"2014","journal-title":"J Burn Care Res"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib81","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5001\/omj.2017.82","article-title":"Vaginal reconstruction for vaginal obliteration secondary to Stevens Johnson syndrome: a case report and review of literature","volume":"32","author":"Boyraz","year":"2017","journal-title":"Oman Med J"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.066_bib82","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2006.01586.x","article-title":"Vaginal adenosis induced by Stevens-Johnson syndrome","volume":"20","author":"Emberger","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1083-3188(02)00146-8","article-title":"Vaginal adhesions caused by Stevens-Johnson syndrome","volume":"15","author":"Hart","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib84","first-page":"81","article-title":"Prevention of vulvovaginal sequelae in Stevens-Johnson syndrome and\u00a0toxic epidermal necrolysis","volume":"4","author":"Kaser","year":"2011","journal-title":"Rev Obstetr Gynecol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib85","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.2005.06751.x","article-title":"Vulval adenosis associated with toxic epidermal necrolysis","volume":"153","author":"Noel","year":"2005","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.burns.2015.03.012","article-title":"Complications of Stevens-Johnson syndrome beyond the eye and skin","volume":"42","author":"Saeed","year":"2016","journal-title":"Burns"},{"issue":"3 Pt 2","key":"10.1016\/j.jaad.2020.02.066_bib88","first-page":"478","article-title":"Vulvovaginal sequelae of Stevens-Johnson syndrome and their management","volume":"71","author":"Wilson","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.jaad.2020.02.066_bib89","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20100500","article-title":"Estrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities","volume":"207","author":"Campbell","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2020.02.066_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222720","article-title":"Novel management of vaginal chronic graft-versus-host disease causing haematometra and haematocolpos","volume":"2018","author":"Buchan","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib91","first-page":"e368","article-title":"Estrogen treatment of acetic acid burns to the vagina, cervix, and perineum: a case report and review of the literature","volume":"35","author":"Ching","year":"2014","journal-title":"J Burn Care Res"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib92","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)65217-0","article-title":"Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response","volume":"155","author":"Ashcroft","year":"1999","journal-title":"Am J Pathol"},{"issue":"1-2","key":"10.1016\/j.jaad.2020.02.066_bib93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2013.05.015","article-title":"Estrogen receptor-mediated signalling in female mice is locally activated in response to wounding","volume":"375","author":"Emmerson","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib94","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2019.05.061","article-title":"Distinguishing Stevens-Johnson syndrome\/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation--a retrospective chart review","volume":"81","author":"Weinkle","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.02.066_bib95","article-title":"Intensive care in a patient with toxic epidermal necrolysis","volume":"2017","author":"Wallenborn","year":"2017","journal-title":"Case Rep Crit Care"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib96","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients","volume":"34","author":"Boorboor","year":"2008","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib97","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.burns.2017.10.012","article-title":"Efficacy and feasibility of opioids for burn analgesia: an evidence-based qualitative review of randomized controlled trials","volume":"44","author":"Yang","year":"2018","journal-title":"Burns"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/157488612805076570","article-title":"Deciphering supportive treatment strategies for toxic epidermal necrolysis","volume":"7","author":"Jennes","year":"2012","journal-title":"Curr Drug Saf"},{"issue":"5 Suppl 1","key":"10.1016\/j.jaad.2020.02.066_bib99","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.2146\/ajhp150367","article-title":"Assessment of low-dose i.v. ketamine infusions for adjunctive analgesia","volume":"73","author":"Kator","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.pain.2011.01.055","article-title":"Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial","volume":"152","author":"Gray","year":"2011","journal-title":"Pain"},{"issue":"18","key":"10.1016\/j.jaad.2020.02.066_bib101","doi-asserted-by":"crossref","first-page":"e15343","DOI":"10.1097\/MD.0000000000015343","article-title":"Pregabalin in the reduction of pain and opioid consumption after burn injuries: a preliminary, randomized, double-blind, placebo-controlled study","volume":"98","author":"Jones","year":"2019","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib102","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.burns.2017.07.018","article-title":"Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: a retrospective chart review","volume":"44","author":"Kaul","year":"2018","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/BCR.0b013e31828a4828","article-title":"Gabapentin is ineffective as an analgesic adjunct in the immediate postburn period","volume":"35","author":"Wibbenmeyer","year":"2014","journal-title":"J Burn Care Res"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib104","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.burns.2018.01.019","article-title":"Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: epidemiology and general microbiological characteristics","volume":"44","author":"Lipovy","year":"2018","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","article-title":"Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures","volume":"89","author":"de Prost","year":"2010","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3904\/kjim.2012.27.2.203","article-title":"Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients","volume":"27","author":"Kim","year":"2012","journal-title":"Korean J Intern Med"},{"issue":"8","key":"10.1016\/j.jaad.2020.02.066_bib107","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","article-title":"Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre","volume":"35","author":"Rajaratnam","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib108","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1744-9987.2008.00609.x","article-title":"Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan","volume":"12","author":"Yamada","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib109","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaad.2019.05.096","article-title":"Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: a cohort study of 176 patients","volume":"81","author":"Koh","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamadermatol.2014.4844","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remission","volume":"151","author":"Bequignon","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib111","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cps.2017.02.016","article-title":"Burn center care of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"44","author":"Cartotto","year":"2017","journal-title":"Clin Plast Surg"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib113","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib114","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/BCR.0000000000000062","article-title":"Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patients","volume":"35","author":"Mahar","year":"2014","journal-title":"J Burn Care Res"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.066_bib115","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1365-4632.2011.05007.x","article-title":"Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"50","author":"Ang","year":"2011","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2020.02.066_bib116","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.13309","article-title":"Toxic epidermal necrolysis with isolated neutropenia related to the use of levetiracetam","volume":"43","author":"Oh","year":"2016","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib117","first-page":"269","article-title":"Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis\u2013experience with 3 patients","volume":"11","author":"Mahajan","year":"2013","journal-title":"Skinmed"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib118","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2133.2009.09585.x","article-title":"Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected]","volume":"162","author":"de Sica-Chapman","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.02.066_bib119","first-page":"Doc30","article-title":"Does hypernatremia impact mortality in toxic epidermal necrolysis?","volume":"8","author":"Namdar","year":"2010","journal-title":"Ger Med Sci"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/BCR.0b013e3181cb8cb8","article-title":"What are the fluid requirements in\u00a0toxic\u00a0epidermal necrolysis?","volume":"31","author":"Shiga","year":"2010","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.burns.2009.06.213","article-title":"Toxic epidermal necrolysis (Lyell's disease)","volume":"36","author":"Lissia","year":"2010","journal-title":"Burns"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib122","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib123","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BCR.0b013e31817db8c8","article-title":"Blister fluid composition in a pediatric patient with toxic epidermal necrolysis","volume":"29","author":"Gandhi","year":"2008","journal-title":"J Burn Care Res"},{"issue":"5","key":"10.1016\/j.jaad.2020.02.066_bib124","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/BCR.0b013e3181eed441","article-title":"Toxic epidermal necrolysis in pregnancy: case report and\u00a0review of the literature","volume":"31","author":"Struck","year":"2010","journal-title":"J Burn Care Res"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib125","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s12325-017-0530-y","article-title":"Stevens-Johnson syndrome and\u00a0toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures","volume":"34","author":"Schneider","year":"2017","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib126","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Exp Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib127","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib128","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.jaad.2017.05.057","article-title":"Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"77","author":"Schneider","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave","year":"2005","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-277X.2006.00685.x","article-title":"Nutrition of toxic epidermal necrolysis","volume":"19","author":"Gravante","year":"2006","journal-title":"J Hum Nutr Diet"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition\u2013a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib132","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0884533616642746","article-title":"Nutrition in toxic epidermal necrolysis: a multicenter review","volume":"31","author":"Graves","year":"2016","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib133","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"issue":"13","key":"10.1016\/j.jaad.2020.02.066_bib134","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.burns.2015.10.025","article-title":"Moderate glycemic control safe in critically ill adult burn patients: a 15 year cohort study","volume":"42","author":"Stoecklin","year":"2016","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00134-016-4523-0","article-title":"Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"43","author":"Yamada","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib137","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00134-016-4558-2","article-title":"The optimal target for acute glycemic control in critically ill patients: a network meta-analysis","volume":"43","author":"Yatabe","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib138","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13054-017-1937-1","article-title":"Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis","volume":"22","author":"Huang","year":"2018","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.jaad.2020.02.066_bib139","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0148607112436978","article-title":"Stress prophylaxis in intensive care unit patients and the role of enteral nutrition","volume":"36","author":"Hurt","year":"2012","journal-title":"J Parenter Enteral Nutr"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.066_bib140","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1345\/aph.1A083","article-title":"Use of enteral nutrition for stress ulcer prophylaxis","volume":"35","author":"MacLaren","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib141","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/BCR.0000000000000329","article-title":"Predicting mechanical ventilation and mortality: early and late indicators in Steven-Johnson syndrome and toxic epidermal necrolysis","volume":"37","author":"Beck","year":"2016","journal-title":"J Burn Care Res"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib142","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation","volume":"42","author":"de Prost","year":"2014","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.066_bib143","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s001340050492","article-title":"Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study","volume":"23","author":"Lebargy","year":"1997","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib144","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.burns.2017.01.005","article-title":"A draft of bronchoscopic grading system in patients with toxic epidermal necrolysis","volume":"43","author":"Lipovy","year":"2017","journal-title":"Burns"},{"issue":"9","key":"10.1016\/j.jaad.2020.02.066_bib145","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1346-8138.2006.00142.x","article-title":"Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro\/SS-A and a review of the published work","volume":"33","author":"Kamada","year":"2006","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.066_bib146","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.amjsurg.2015.12.011","article-title":"Indications for intubation and early tracheostomy in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"211","author":"Williams","year":"2016","journal-title":"Am J Surg"},{"issue":"18","key":"10.1016\/j.jaad.2020.02.066_bib147","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.jaad.2020.02.066_bib148","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Guerin","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jaad.2020.02.066_bib149","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/CCM.0b013e31828cf104","article-title":"Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.066_bib150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2020.02.066_bib151","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-015-1003-9","article-title":"Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis","volume":"19","author":"Minet","year":"2015","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jaad.2020.02.066_bib152","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1378\/chest.14-2842","article-title":"Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score","volume":"149","author":"Hostler","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.066_bib153","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220303121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220303121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:56:48Z","timestamp":1759273008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220303121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":153,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0190962220303121"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.02.066","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.02.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}